Access Navigating a path to patients.

Market access in rare diseases and oncology is complex and constantly changing. Each launch is unique, while organisations and reimbursement pathways evolve, meaning our clients must be ready to adapt.

Effectively achieving access demands effective planning, cross-functional alignment and bold, strategic thinking.

How we can support

At Dolon, we guide our clients through complex global payer pathways to ensure launch readiness and deliver on their ambition – providing life-changing treatments to those who need them.

  • Negotiation training

  • Launch excellence workshops

  • P&R lessons learned

  • Early/alternative access strategy

  • Market access planning

The numbers

Extensive
experience

100+

Access projects
delivered

Diverse geographic
knowledge

35+

Markets
navigated

Explore more services

Learn More

Want to understand how we can optimise your access planning and execution?